David Lyon, a 26-year-old sheet metal worker, experienced alarming symptoms including blood in his stool and sharp abdominal pain, prompting him to seek medical attention in July 2021. Following a colonoscopy, he was diagnosed with Stage IV colorectal cancer that had metastasized to his liver. Despite his anger at the diagnosis, Lyon opted for aggressive treatment without knowing his prognosis, which typically carries a low five-year survival rate for his stage of cancer. Over the next three years, he underwent chemotherapy and surgery, while maintaining his active lifestyle, including playing hockey. Ultimately, after struggling to manage the cancer’s spread, Lyon received a liver transplant in August 2024, a treatment option recently approved for colorectal cancer patients with liver metastases.
Why It Matters
The increasing incidence of colorectal cancer among young adults is a significant concern, with diagnoses and mortality rates rising annually among those aged 20 to 49. Factors contributing to this trend include diet, lifestyle, family history, and obesity, though the exact causes remain unclear. Colorectal cancer has emerged as a leading cancer-related cause of death in this age group, underscoring the need for awareness of symptoms such as rectal bleeding and abdominal pain. The recent advancement in treatment options, like liver transplants for metastatic cases, provides new hope for patients facing similar challenges.
Want More Context? 🔎
